MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast - Episode Library
  • Patient Community Day at ECTRIMS 2025
  • Multiple Sclerosis in 2025 – Key Developments to Date
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us

Tagged Conferences

ECTRIMS 2022

ECTRIMS 2022: Daily Podcasts & Summary Videos

MStranslate
November 21, 2022
Conferences, ECTRIMS, Research
The 38th meeting of the European Congress for the Treatment and Research Into Multiple Sclerosis (ECTRIMS) took place in Amsterdam, The Netherlands,...
Dr Barry Singer

ACTRIMS Forum 2022 Insights – Dr Barry Singer

MStranslate
April 4, 2022
ACTRIMS, Conferences, Research
The Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) held its annual meeting between February 24 and 26 in West Palm...
ECTRIMS Congress 2021

ECTRIMS Congress 2021: Research Insights

MStranslate
October 18, 2021
Conferences, Dr Travis Stiles, ECTRIMS, Research, Videos
Due to the ongoing challenges and restrictions of the COVID-19 pandemic, ECTRIMS Congress 2021 was once again held as a virtual conference this year....
ACTRIMS Forum 2021

ACTRIMS Forum 2021 – Virtual Meeting Coverage

MStranslate
February 28, 2021
ACTRIMS, Conferences, Hormones, Research, Videos
In 2021, the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum was set to take place in Phoenix, Arizona, between...
ECTRIMS 2019

ECTRIMS 2019: Review of Online Coverage

MStranslate
September 18, 2019
Conferences, ECTRIMS
While ECTRIMS 2019 is officially over, our coverage of it will continue during the coming weeks.  There are three reasons for this.  Firstly, there...
Gut Microbiome

ECTRIMS 2018: The Gut Microbiome in MS

MStranslate
November 19, 2018
Conferences, ECTRIMS, Research
1 Comment
"It is intriguing...can you modulate the gut microbiome to improve outcomes in MS, such as reducing relapse rates? That would be a fabulous end...
ECTRIMS Congress 2018

ECTRIMS Congress 2018 Coverage – Day 3

MStranslate
October 18, 2018
Conferences, ECTRIMS, Research
1 Comment
This year, MStranslate invested in travelling to the ECTRIMS Congress 2018, recognising it’s the easiest and most efficient way to inform our...
ECTRIMS Congress 2018

ECTRIMS Congress 2018 Coverage – Day 2

MStranslate
October 15, 2018
Conferences, ECTRIMS, Research
2 Comments
This year, MStranslate invested in travelling to the ECTRIMS Congress 2018, recognising it’s the easiest and most efficient way to inform our...
ECTRIMS Congress 2018

ECTRIMS Congress 2018 Coverage – Day 1

MStranslate
October 11, 2018
Conferences, ECTRIMS, Research
2 Comments
This year, MStranslate has invested in travelling to the ECTRIMS Congress 2018, recognising it's the easiest and most efficient way to inform our...
ECTRIMS 2016

ECTRIMS 2016: An Overview of Key Outcomes

MStranslate
September 22, 2016
Conferences, ECTRIMS, Research, Social Media
Each year, the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) holds the largest MS research meeting in the world.  ...
  1. 1
  2. 2

Recent Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Recent Comments

  • FDA Decision On Tolebrutinib - MStranslate on Multiple Sclerosis in 2025 – Key Developments to Date
  • Treatment With Gut Bacteria Shows Benefits In New Study on Gut Bacteria in People Living with RRMS
  • Community Q&A: COVID-19 Vaccines & Multiple Sclerosis on Community Q&A: The Blood-Brain Barrier
  • Community Q&A: Why Don't We Have A Multiple Sclerosis Cure? on Community Q&A: COVID-19 Vaccines & MS
  • Tim Little on FAKE NEWS ALERT: COVID Vaccines & MS

Calendar

March 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
« Jan    

Archives

Categories

Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.